The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Fecal microbiota transplantation has significantly improved progression-free survival in patients with metastatic renal cell ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

The study added to a limited database about the effects of perioperative IO combinations, which have emerged as standard of ...

Ratios of visceral proteins can act as independent indicators for both overall and progression-free survival in patients with ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...

With two additional months of follow-up, relative progression-free survival has further improved in the analysis of all patients treated with GRANITE, and most notably, in those with a lower tumor ...

THURSDAY, Oct. 31, 2024 (HealthDay News) -- Inavolisib plus palbociclib-fulvestrant yields significantly longer ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

The primary endpoint will be median progression-free survival where the placebo benchmark is expected to be approximately six ...